Position in IMCR
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,632,585
+$388,566 QoQ
Shares Held
51,420
+24.6% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#63
of 136 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALPS ADVISORS INC holds $213,436,831 across 115 Biotechnology names. IMCR ranks #47 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
315,335 | $17,680,833 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
62,523 | $8,298,677 | |
| 3 | CGON |
CG Oncology, Inc.
|
89,218 | $6,338,938 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
97,610 | $5,891,739 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
61,014 | $5,806,702 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
55,281 | $5,388,791 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
93,981 | $5,339,060 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
110,388 | $5,192,651 |
All Filings in IMCR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,632,585 | 51,420 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $1,244,019 | 41,261 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $1,440,013 | 41,487 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $884,235 | 24,339 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $849,644 | 27,076 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $1,063,254 | 35,836 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $1,193,393 | 40,454 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,193,835 | 38,350 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,289,853 | 38,060 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,283,775 | 35,135 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,281,204 | 33,390 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,877,119 | 36,168 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,227,813 | 37,155 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,566,209 | 31,679 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $1,751,763 | 30,695 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,124,588 | 23,958 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $952,375 | 25,526 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,322,357 | 44,226 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,734,940 | 50,670 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $1,989,287 | 53,663 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,236,510 | 57,273 | Shares | Defined | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||